|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Georgia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing GeorgiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Vaxart, Inc.
| Vaxart, Inc. 2500 Northwinds Parkway, Suite 100 Alpharetta, GA 30009 | |
| | Phone: | (678) 221-3343 | Year Established: | 1967 | Employees: | 35 | Ticker: | VXRT | Exchange: | NASDAQ | Main Contact: | Wouter Latour, MD MBA, President & CEO | | Other Contacts: | David Taylor, M.D., CMO Brant Biehn, Senior VP, Commercial Operations Jonas Niaura, VP, Corporate Development & Strategy Simon Tucker BSc (Hons), Ph.D., VP, Research Leigh Farrell BSc (Hons), FAICD, Ph.D., VP, Business Development Russell H. Plumb, Chairman Mark P. Colonnese, Executive VP & CFO
| | Company Description | Vaxart, formerly, Aviragen Therapeutics, Biota Parma & Nabi Biopharmac) is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick injury. Its development programs are oral tablet vaccines designed to protect against norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart's first immuno-oncology indication.
On Oct. 30, 2010, Aviragen Therapeutics and Vaxart announced a definitive merger agreement. The merger will result in a combined company, Vaxart, Inc., focused on developing orally-delivered therapeutics and prophylactics to address a variety of viral infections. | |
|
|
|
|
|